US Broker Ratings

Universal Health Services, Inc. (UHS) Stock Analysis: Strong Upside Potential with Robust Financials

Universal Health Services, Inc. (NYSE: UHS) continues to capture the attention of investors with its solid foundation in the healthcare sector, specifically within the medical care..

Grifols, S.A. (GRFS) Stock Analysis: A 39.65% Upside Potential in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the healthcare sector specializing in the production of plasma-derived medicines, presents a compelling opportunity for investors seeking to..

Elanco Animal Health (ELAN) Stock Analysis: Strong Buy Ratings and a Promising 31.87% Upside

For investors seeking opportunities in the healthcare sector, Elanco Animal Health Incorporated (NYSE: ELAN) presents a compelling case. As a leader in the animal health industry,..

Globus Medical (GMED) Stock Analysis: Navigating a 20% Potential Upside with Healthcare Innovation

Globus Medical, Inc. (GMED), a prominent player in the healthcare sector with a focus on medical devices, offers an intriguing investment proposition with a market capitalization..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Unpacking a 21% Potential Upside

As investors seek promising opportunities within the healthcare sector, Intuitive Surgical, Inc. (NASDAQ: ISRG) stands out with a compelling proposition. With a market capitalization of $141.34..

Chemed Corp (CHE) Investor Outlook: Exploring Growth Potential with a 3.59% Upside

Chemed Corp (NYSE: CHE), a key player in the healthcare sector, is a diversified company with a significant presence in the medical care facilities industry. Headquartered..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 34.44% Upside Potential Beckons Investors

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a prominent player in the biotechnology sector, presents an intriguing investment case with its focus on developing therapies for rare and..

Penumbra, Inc. (PEN) Stock Analysis: Exploring a 10.65% Potential Upside in the Healthcare Sector

Penumbra, Inc. (NYSE: PEN), a prominent player in the healthcare sector, particularly within the medical devices industry, stands as a compelling investment opportunity. With a market..

Koninklijke Philips N.V. NY Reg (PHG) Stock Analysis: Exploring an 18% Upside Potential in Healthcare Innovation

As investors navigate the dynamic landscape of medical technology, Koninklijke Philips N.V. (PHG) emerges as a compelling player with significant growth potential. With a market capitalization..

BioNTech SE (BNTX) Stock Analysis: A 29.90% Potential Upside Amidst a Challenging Landscape

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has carved a niche for itself in the development and commercialization of innovative immunotherapies. As..

AstraZeneca PLC (AZN) Stock Analysis: Exploring a 36.59% Potential Upside and Strong Buy Ratings

AstraZeneca PLC (NASDAQ: AZN), a global leader in the biopharmaceutical sector, remains a focal point for investors due to its substantial market capitalization and promising growth..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 15.52% Upside Potential with Strong Buy Ratings

Roivant Sciences Ltd. (NASDAQ: ROIV), a burgeoning player in the biotechnology sector, has captured the attention of investors with its promising clinical-stage developments and a robust..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a 6.88% Potential Upside in the Medical Device Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a formidable player in the healthcare sector, specifically within the rapidly advancing medical devices industry. With a market..

Moderna, Inc. (MRNA) Stock Analysis: Navigating the Biotech Giant’s Potential in a Volatile Market

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, has been at the forefront of mRNA technology since its inception in 2010. Headquartered in..

Summit Therapeutics Inc. (SMMT) Stock Analysis: A 114% Potential Upside Amid Biotech Innovations

Summit Therapeutics Inc. (SMMT), a pioneering player in the biotechnology sector, has captured significant attention among investors, not least because of its substantial potential upside of..

ICON plc (ICLR) Stock Analysis: Strong Buy Ratings and 13.74% Potential Upside Highlight Investment Appeal

ICON plc (NASDAQ: ICLR), a leader in the healthcare sector through its specialization in diagnostics and research, is catching the eye of investors with a compelling..

Genmab A/S (GMAB) Stock Analysis: A 21.59% Upside Potential Amid Robust Revenue Growth

As investors seek opportunities in the dynamic biotechnology sector, Genmab A/S (NASDAQ: GMAB) emerges as a compelling candidate with a market cap of $19.63 billion. Headquartered..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 12.93% Potential Upside for Investors

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the healthcare sector, particularly in the medical devices industry, presents a compelling case for investors seeking..

AbbVie Inc. (ABBV) Stock Analysis: Navigating Growth with a 10.74% Potential Upside

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, continues to capture investor interest with its formidable presence in the pharmaceutical industry. Boasting a market..

Gilead Sciences, Inc. (GILD) Stock Analysis: A Promising 13.77% Upside with Strong Buy Ratings

Gilead Sciences, Inc. (NASDAQ: GILD), a leader in the biopharmaceutical sector, continues to stand out as a compelling investment opportunity. As a major player in the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds